EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS

Michael T Truver iD, Gerd Jakobsson iD, Maria D Chermà iD, Madeleine J Swortwood, Henrik Gréen, Robert Kronstrand iD

Journal of Analytical Toxicology · 24.01.2023 · 46 (9) · 1025-1031

DOI: 10.1093/jat/bkab123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Analytical Toxicology, online erschienen am 18.12.2021. Verfasst von Michael T Truver und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping 581 83, Sweden. Hauptthemen laut MEDLINE: Analgesics, Opioid, Oxycodone. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Strategic Research Area in Forensic Sciences at Linkoping University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxycodone (OC) is a schedule II semisynthetic opioid in the USA that is prescribed for its analgesic effects and has a high potential for abuse. Prescriptions for OC vary based on the dosage and formulation, immediate release (IR) and controlled release (CR). Monitoring OC metabolites is beneficial for forensic casework. The limited studies that involve pharmacokinetics of the urinary excretion of OC metabolites leave a knowledge gap regarding the excretion of conjugated and minor metabolites, pharmacokinetic differences by formulation, and the impact of CYP2D6 activity on the metabolism and excretion of OC. The objectives of this study were to compare urinary excretion of phase I and II metabolites by formulation and investigate if ratio changes over time could be used to predict the time of intake. Subjects (n = 7) received a single 10 mg IR tablet of Oxycodone Actavis. A few weeks later the same subjects received a single 10 mg CR tablet of Oxycodone Actavis. During each setting, urine was collected at 0, 0.5, 1, 1.5, 2, 3, 4, 5, 6, 8, 9, 10, 12, 14, 24, 48 and 72 h. Urine samples (100 µL) were diluted with 900 µL internal standard mixture and analyzed on an Acquity UPLC® I-class coupled to a Waters Xevo TQD using a previously validated method. The CYP2D6 phenotypes were categorized as poor metabolizers (PM), intermediate metabolizers (IM), extensive metabolizers (EM) and ultrarapid metabolizers (UM). Comparisons between IR and CR were performed using two-tailed paired t-test at a significance level of P = 0.05. The metabolite ratios showed a general increase over time. Four metabolite to parent ratios were used to predict the time of intake showing that predictions were best at the early time points.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidOxycodoneChromatography, LiquidCytochrome P-450 CYP2D6Delayed-Action PreparationsTandem Mass SpectrometryHumans

Substanzen

Analgesics, OpioidCytochrome P-450 CYP2D6Delayed-Action PreparationsOxycodone

Autor:innen und Institutionen

  • Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping 581 83, Sweden.
  • Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, 4800 SW 35th Drive, Gainesville, FL 32610, USA.
  • Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Artillerigatan 12, Linköping 587 58, Sweden.
  • Department of Forensic Science, College of Criminal Justice, Sam Houston State University, 1003 Bowers Blvd, Huntsville, TX 77340, USA.

ORCID-Profile: Michael T Truver, Gerd Jakobsson, Maria D Chermà, Robert Kronstrand

Förderung

  • Strategic Research Area in Forensic Sciences at Linkoping University

Zitieren

APA

Truver, M. T., Jakobsson, G., Chermà, M. D., Swortwood, M. J., Gréen, H., & Kronstrand, R. (2023). Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS. Journal of Analytical Toxicology, 46(9), 1025-1031. https://doi.org/10.1093/jat/bkab123

Vancouver

Truver MT, Jakobsson G, Chermà MD, Swortwood MJ, Gréen H, Kronstrand R. Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS. Journal of Analytical Toxicology. 2023;46(9):1025-1031. doi:10.1093/jat/bkab123

BibTeX
@article{Truver2023,
  author = {Truver, Michael T and Jakobsson, Gerd and Chermà, Maria D and Swortwood, Madeleine J and Gréen, Henrik and Kronstrand, Robert},
  title = {Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS},
  journal = {Journal of Analytical Toxicology},
  year = {2023},
  volume = {46},
  number = {9},
  pages = {1025--1031},
  doi = {10.1093/jat/bkab123}
}
Kostenlos starten →